Trans-national Access Call: COVID-19 Therapeutics Pipeline
With this free-of-charge TA Call `COVID-19 Therapeutics Pipeline´, INFRAFRONTIER is providing researchers access to test their innovative and novel COVID-19 therapeutics in a standardised infection pipeline that uses preclinical models to study COVID-19 infection.
Context and aims of the call
Main objective of this INFRAFRONTIER2020 Trans-national Access Call is to provide extensive user support to the selected projects for assessing novel potential vaccine and treatment compounds for COVID-19. As starting material for the TA service, only sufficient amounts of the therapeutic candidate and desired mode of administration will be provided by the TA call users. It will be incumbent upon users to provide these materials and information.
Viral particles, COVID-19 mouse models, cohort production and BSL3 pipeline analysis will be provided by INFRAFRONTIER partners - CIPHE and CCP. Further functional analysis and advanced readouts like organ histopathological analysis, multiplex assay profiling of cytokines and chemokines in lung and mouse serum etc. can be provided on a collaborative basis outside the scope of this TA call. A final infection profile report will be provided as a deliverable.
Please contact info@infrafrontier.eu if you have any questions